Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Apple Inc. (AAPL), Tesla Motors Inc (TSLA): Ambitions & Roadblocks

Trademark trolls strike again in China.

In 2006, Chinese businessman Zhan Baosheng registered the Tesla name and trademark. The company’s “dream is to build China’s best electric car.” Meanwhile California-based Tesla Motors Inc (NASDAQ:TSLA)‘s dream to produce the world’s best electric car is coming true — in fact the company sold 5,150 of them in the second quarter. Should Tesla Motors Inc (NASDAQ:TSLA)’ investors worry about Zhan Baosheng?

Tesla Motors Inc (NASDAQ:TSLA)

Ambitions and roadblocks
Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk is known for his ambition. He hopes to nearly double Model S sales in 2014 and expand the company’s Supercharger stations in the U.S. from about 30 today to cover 98% of the population by 2015. Even more, he hopes to hit the right note with the mass market in three to five years, when the company plans to bring an affordable car to market.

These ambitions are certainly exciting for investors, but what happens if Tesla Motors Inc (NASDAQ:TSLA) runs into a few roadblocks on the way? Already the company is facing litigation to stop it from bypassing dealer franchises and selling directly to consumers. And now Tesla might be forced to hand out some cash to gain access to the world’s largest auto market.

As Reuters pointed out, Apple Inc. (NASDAQ:AAPL) had to cough up $60 million last year for the rights to the iPad trademark in China. On a GAAP basis, Tesla Motors reported a $30.5 million loss in the second quarter of 2013. Is a $60 million roadblock something Tesla can weather?

Some perspective
Any roadblock that slows Tesla Motors Inc (NASDAQ:TSLA) down most likely won’t go over well with investors — and, more importantly, it will affect the stock price. At today’s price, Musk’s ambitions are mostly already priced into the stock, leaving little room for hiccups.

Fortunately, however, this trademark issue seems more like a headache than a roadblock. At Tesla’s current sales levels, $60 million is just a sliver of the company’s most recent quarterly GAAP revenue of $401.5 million, which should continue upward. Even more, the Street’s faith in the stock has infused the company with new capital. In the last month alone, the stock’s market capitalization grew by about $4 billion.

Sure, Tesla Motors Inc (NASDAQ:TSLA) could win rights to the trademark with nothing more than legal fees. But if Tesla does have to dish out a nice sum to enter the important Chinese market, it’s a small enough problem to affect an investment thesis.

The article Tesla Trademark Issues in China: Should Investors Worry? originally appeared on and is written by Daniel Sparks.

Fool contributor Daniel Sparks owns shares of Apple and Tesla Motors. The Motley Fool recommends Apple and Tesla Motors. The Motley Fool owns shares of Apple and Tesla Motors.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.